Allergan: Pershing Square files amended 13D filing; sends letter to board
On July 15, 2014, Pershing Square and Valeant (VRX) entered into an indemnification letter agreement relating to Valeant's previously announced exchange offer. Filing includes letter addressed to AGN board, saying among other things, they are now working to obtain the consents to call a special meeting, and upon their receipt, will ask the board to call the meeting.